Eli Lilly has cut the prices of its two lowest doses of weight-loss drug Zepbound by releasing them as single-dose vials, the company announced Tuesday.

Eli Lilly said the two lowest doses of Zepbound, 2.5 milligrams and 5 milligrams, are now available as single-dose vials for significantly lower prices. This means that patients using single-dose vials will need to use a syringe to draw out the medication instead of an auto-injector pen.

A month’s supply of the 2.5 milligrams dosage will cost $399 while a month’s........

© The Hill